Misuse preventative, controlled release formulation

Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a superabsorbent material (for example, polycarbophil), a controlled release coat surrounding the core, and a plurality of controlled release...

M Rahmouni，A Ferrada，F Soulhi，... - US

Oral controlled release formulation for sedative and hypnotic agents

The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administr...

XC Xiu，D Tian - US

Misuse preventative, controlled release formulation

Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a pharmaceutically active agent (for exampl...

RAHMOUNI MILOUD，GERVAIS SONIA，SANT VINAYAK，...

Oral controlled release formulation for sedative and hypnotic agents

The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administr...

XX Cheng，D Tian - US

PAROXETINE FORMULATIONS

not available for EP1791531of corresponding document: WO2006023347 Paroxetine is a drug used to treat psychiatric problems such as depression. Controlled release dosage forms comprising release-retarding materials other than hydroxypropy...

Z Vilkov，G Boehm - US

Controlled release paroxetine-containing tablets based on a core and a coating

The invention provides a controlled release tablet comprising of: (i) a core consisting of paroxetine or its pharmaceutically acceptable salt, at least one rate controlling hydrophilic polymer, a diluent, a binder and a lubricant; and (i...

J Desai，K Patel，J Pranav，... - WO

Method of treating thermoregulatory dysfunction with paroxetine

The present invention relates to a method for treating a patient suffering from a thermoregulatory dysfunction, especially hot flashes and flushes associated with hormonal changes due to naturally occurring menopause (whether male or fem...

PAT Richards - US

PHARMACEUTICAL PREPARATIONS ON THE BASIS OF MOISTURE-PROTECTED GRANULES AND A PROCESS FOR PRODUCING THEM

This invention describes novel pharmaceutical preparations and a process of production thereof. It is preferred that the preparation comprises a stabilized oral dosage form of an active pharmaceutical ingredient (API) such as paroxetine ...

RAMACHANDRAN THEMBALATH，YATISH KUMAR BANSAL，VEENA SINGH - WO

FORMULATION AND METHOD FOR THE RELEASE OF PAROXETINE IN THE LARGE INTESTINE

The present invention provides a delayed and/or controlled release formulation of paroxetine or a pharmaceutically acceptable salt thereof that is formulated to release a substantial portion of the active ingredient (e.g., paroxetine) in...

J Neely，DJ Wargo，B Li，...

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR

The present invention provides a controlled release pharmaceutical composition comprising selective serotonin reuptake inhibitor and a process for preparation thereof. The controlled release pharmaceutical composition comprises: a deposi...

JAHAGIRDAR Harshal，KATKAR Ganesh，DALAL Satish Kumar，... - WO